ASTHMANEFRIN  - racepinephrine hydrochloride solution 
Nephron Pharmaceuticals Corporation

Disclaimer: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.

----------

Nephron Pharmaceuticals Corporation

OTC - ACTIVE INGREDIENT

Racepinephrine, USP 11.25 mg (as 13.5 mg of Racepinephrine HCl, USP)

OTC - PURPOSE

Bronchodilator

INDICATIONS AND USAGE

For temporary relief of shortness of breath, tightness of chest, and wheezing due to bronchial asthma.
Eases breathing for asthma patients by reducing spasms of bronchial muscles.

OTC - DO NOT USE

Warnings

Do not use this product unless a diagnosis of asthma has been made by a doctor.
Do not use this product if you have heart disease, high blood pressure, thyroid disease, diabetes, or difficulty in urination due to enlargement of the prostate gland unless directed by a doctor.
Do not use this product if you have ever been hospitalized for asthma or if you are taking any prescription drug for asthma unless directed by a doctor.
Do not use if you are now taking a prescription monoamine oxidase inhibitor (MAOI) (certain drugs for depression, psychiatric, or emotional conditions, or Parkinson’s disease), or for 2 weeks after stopping the MAOI drug.  If you do not know if your prescription drug contains an MAOI, ask a doctor or pharmacist before taking this product.
Do not use this product more frequently or at higher doses than recommended unless directed by a doctor.  Excessive use may cause nervousness and rapid heart beat, and, possibly, adverse effects on the heart.
Do not continue to use this product, but seek medical assistance immediately if symptoms are not relieved within 20 minutes or become worse.
Do not use this product if it is brown in color or cloudy.

OTC - PREGNANCY OR BREAST FEEDING

If pregnant or breast-feeding, ask a health professional before use.

OTC - KEEP OUT OF REACH OF CHILDREN

Keep out of reach of children.  In case of overdose, get medical help or contact a Poison Control Center right away.

DOSAGE AND ADMINISTRATION

The ingredient is used in an aqueous solution at a concentration equivalent to 1 percent epinephrine.
For use in an atomizer (ie., EZ Breathe Atomizer).
Add 0.5 ml (contents of one vial) of solution to atomizer.
Inhalation dosage for adults, children 12 years of age and over, and children 4 to under 12 years of age: 1 to 3 inhalations not more often than every 3 hours.
The use of this product by children should be supervised by an adult.
Children under 4 years of age: Consult a doctor.

HOW SUPPLIED

AsthmanefrinTM Racepinephrine Inhalation Solution, USP 2.25% is supplied in 0.5 ml sterile unit-of-use vials.

NDC 0487-2784-10 Starter Kit contains 1 EZ Breathe Atomizer and 10 vials, each in an individual foil pouch.

NDC 0487-2784-01 Refill Carton contains 30 vials, each in an individual foil pouch.

Storage and Handling

Protect from light.  Avoid excessive heat.
Store at room temperature, between 20° - 25° C (68° and 77°F).

INACTIVE INGREDIENT

Ascorbic acid, citric acid, edetate disodium, water for injection.

OTC - QUESTIONS

1-855-999-EZAN (3926)

Monday through Friday, 8:00 a.m. to 5:00 p.m. (Eastern Standard Time).

Manufactured By:

Nephron Pharmaceuticals Corporation

Orlando, FL  32811

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Principal Display Panel – Foil Pouch

NDC 0487-2784-10 Starter Kit.

NDC 0487-2784-01 Refill.

AsthmanefrinTM

Racepinephrine Inhalation Solution, USP 2.25%

FOR ORAL INHALATION ONLY

Drug Facts

Active Ingredient: Racepinephrine, USP

Purpose: Bronchodilator

Each 0.5mL contains 11.25mg (as 13.5mg of Racepinephrine HCl, USP).

Uses: For temporary relief of shortness of breath, tightness of chest, and wheezing due to bronchial asthma.

See product carton for detailed information on Uses, Warnings, and Directions.

Other Information: Store at room temperature, between 20° - 25°C (68° and 77°F). Protect from light.

Inactive Ingredients: Ascorbic acid, citric acid, edetate disodium, water for injection.

TAMPER EVIDENT FEATURE:

Do not use this product if the pouch is damaged or torn.

Do not use this product if it is brown in color or cloudy.

STERILE

One 0.5mL Unit-of-Use Vial

d88ffc48-figure-01

Principal Display Panel – Carton (Starter Kit -1 EZ Breathe Atomizer and 10 individually wrapped vials)

NDC 0487-2784-10

AsthmanefrinTM

Racepinephrine Inhalation Solution, USP 2.25%

Bronchodilator

FOR ORAL INHALATION ONLY

TAMPER EVIDENT FEATURE:

Do not use this product if the pouch is damaged or torn.

SULFITE-FREE

PRESERVATIVE-FREE

Neprhon Pharmaceuticals Corporation

Orlando, FL 32811

10 x 0.5mL Sterile Unit-of-Use Vials, each in a foil pouch.

d88ffc48-figure-02

Principal Display Panel – Carton (Refill 30 individually wrapped vials)

NDC 0487-2784-01

AsthmanefrinTM

Racepinephrine Inhalation Solution, USP 2.25%

Bronchodilator

FOR ORAL INHALATION ONLY

TAMPER EVIDENT FEATURE:

Do not use this product if the pouch is damaged or torn.

SULFITE-FREE

PRESERVATIVE-FREE

Neprhon Pharmaceuticals Corporation

Orlando, FL 32811

30 x 0.5mL Sterile Unit-of-Use Vials, each in a foil pouch.

d88ffc48-figure-03
d88ffc48-figure-04
d88ffc48-figure-05

ASTHMANEFRIN 
racepinephrine hydrochloride solution
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:0487-2784
Route of AdministrationRESPIRATORY (INHALATION)DEA Schedule    
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
RACEPINEPHRINE HYDROCHLORIDE (RACEPINEPHRINE) RACEPINEPHRINE HYDROCHLORIDE13.5 mg  in 0.5 mL
Inactive Ingredients
Ingredient NameStrength
ASCORBIC ACID.25 mg  in 0.5 mL
CITRIC ACID MONOHYDRATE2.0 mg  in 0.5 mL
EDETATE DISODIUM.1 mg  in 0.5 mL
WATER 
Product Characteristics
Color    Score    
ShapeSize
FlavorImprint Code
Contains    
Packaging
#Item CodePackage DescriptionMultilevel Packaging
1NDC:0487-2784-1010 POUCH ( POUCH) in 1 CARTONcontains a POUCH
11 VIAL, SINGLE-USE ( VIAL) in 1 POUCHThis package is contained within the CARTON (0487-2784-10) and contains a VIAL, SINGLE-USE
10.5 mL in 1 VIAL, SINGLE-USEThis package is contained within a POUCH and a CARTON (0487-2784-10)
2NDC:0487-2784-0130 POUCH ( POUCH) in 1 CARTONcontains a POUCH
21 VIAL, SINGLE-USE ( VIAL) in 1 POUCHThis package is contained within the CARTON (0487-2784-01) and contains a VIAL, SINGLE-USE
20.5 mL in 1 VIAL, SINGLE-USEThis package is contained within a POUCH and a CARTON (0487-2784-01)

Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC monograph finalpart34108/01/2012

Labeler - Nephron Pharmaceuticals Corporation (783905201)
Registrant - Nephron Pharmaceuticals Corporation (783905201)
Establishment
NameAddressID/FEIOperations
Nephron Pharmaceuticals Corporation783905201MANUFACTURE, ANALYSIS, PACK

Revised: 08/2012 Nephron Pharmaceuticals Corporation